API name: cabozantinib   

Certificates: GMP, DMF

CAS No.: 849217-68-1

Chemical name:

Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib(XL184,BMS-907351);N-(4-(6,7-diMethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide(CAS：849217-68-1);XL-186;1,1-cyclopropanedicarboxamChemicalbookide,n'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-n-(4-fluorophenyl)-;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamideCabozantinib(XL184,BMS-907351);Cabozantinib,>=98%

Formula:C28H24FN3O5

Structure:

API name: cabozantinib   

Certificates: GMP, DMF

CAS No.: 849217-68-1

Usage:

Cabozantinib (Cabometyx) is used:to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the cells of the kidneys)；in combination with nivolumab (Opdivo) to treat advanced RCC in patients who have not yet received a treatment for RCC；to treat hepatocellular carcinoma (HCC; a type of liver cancer) in people who were previously treated with sorafenib (Nexafar)；to treat a certain type of thyroid cancer in adults and children 12 years of age and older that has spread to nearby tissues or to other parts of the body and that has not responded to previous a treatment and cannot be treated with radioactive iodine.

JL Pharm is profesional producer and supplier for cabozantinib, we can supply DMF, Local GMP for this product, capacity is 1000kg/year. If you want to order produce cabozantinib, please let us know.